Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine for symptoms of schizophrenia
IRCT20250226064863N1Phase 3Completed
- Sponsor
- Zahedan University of Medical Sciences
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of memantine in schizophrenia, sponsored by Zahedan University of Medical Sciences. Started Mar 2025; status: completed.
02
Drugs
memantine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on IRCT20250226064863N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250226064863N1.